Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Stadler WM, Kuzel T, Roth B, Raghavan D, Dorr FA. Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. J Clin Oncol. 1997 Nov; 15(11):3394-8.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Carcinoma, Transitional Cell
Deoxycytidine
Female
Humans
Male
Middle Aged
Survival Analysis
Treatment Outcome
Urinary Bladder Neoplasms

authors with profiles

Walter M. Stadler